Comparison Of Clinical Application Between Transurethral 1470nm Diode Laser And Plasmakinetic Enucleation Of The Prostate

Objective : To comparatively analyze the safety and short-term prognosis of transurethral 1470 nm diode laser enucleation of the prostate(DiLEP)and transurethral plasmakinetic enucleation of the prostate(PKEP)for the treatment of benign prostatic hyperplasia(BPH).Methods : A total of 126 patients with benign prostatic hyperplasia who underwent DiLEP and PKEP in the Lanzhou University Second Hospital from June2020 to May 2022 were retrospectively analyzed.There were 71 patients in the DiLEP group and 55 patients in the PKEP group.The baseline characteristics of the patients were compared,including age,body mass index(BMI),prostate volume,preoperative hemoglobin level,preoperative sodium level,international prostate symptom score(IPSS),quality of life score(Qo L),International index of erectile function(IIEF-5),total prostate specific antigen(TPSA)and comorbidities.The intraoperative prostate tissue enucleation time,tissue morcellation time,tissue weight,complications,postoperative hemoglobin value,sodium ion value,bladder irrigation time,indwelling catheter time,postoperative hospital stay,complications and total hospitalization cost were recorded.The patients were followed up at 1,3 and 6months after the operation.Results:There was no significant difference in baseline data between the two groups(P>0.05).The bladder flushing time,catheter indentation time and tissue comminution time in DiLEP group were shorter than those in PKEP group,and the differences were statistically significant(P<0.05).The tissue weight of PKEP group was higher than DiLEP group,and the difference was statistically significant(P<0.05).There were no significant differences in enucleation time,postoperative hemoglobin value,postoperative sodium ion value,postoperative hospitalization time,hospitalization cost,intraoperative and postoperative complications(P>0.05).IPSS and Qo L of the two groups were improved after surgery compared with those before surgery,and there was no statistical significance between the two groups at 1 month,3months and 6 months after surgery(P>0.05).IIEF-5 decreased after surgery compared with that before surgery,and there was no significant difference between the two groups 3 months and 6 months after surgery(P>0.05).Conclusion:DiLEP and PKEP are safe and effective with similar efficacy in the treatment of BPH patients with lower urinary tract symptoms.DiLEP shows some advantages over PKEP in reducing bladder flushing time and indwelling urinary catheter time,allowing patients to get out of bed earlier and promoting recovery.